• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hsa_circ_0006988 通过调节 IGF1 来利用 miR-15a-5p 促进肝癌索拉非尼耐药。

Hsa_circ_0006988 Promotes Sorafenib Resistance of Hepatocellular Carcinoma by Modulating IGF1 Using miR-15a-5p.

机构信息

Second General Surgery, Xinyu People's Hospital, Xinyu, China.

出版信息

Can J Gastroenterol Hepatol. 2022 Dec 24;2022:1206134. doi: 10.1155/2022/1206134. eCollection 2022.

DOI:10.1155/2022/1206134
PMID:36594050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9805390/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is the most frequently occurring cancer and contributes to the largest number of cancer-associated deaths worldwide. Recent evidence suggests that circular RNAs (circRNAs), which are critical for HCC etiology and metastasis, are distinctly modulated in HCC. Nevertheless, the underlying mechanism of circRNA-mediated sorafenib resistance (SOR) in HCC is yet to be determined.

METHODS

The hsa_circ_0006988, IGF1, and miR-15a-5p contents were quantified via ELISA and quantitative real-time polymerase chain reaction (qRT-PCR), respectively. Cell Counting Kit-8 (CCK-8) was used for the IC50 evaluation. Lastly, associations among hsa_circ_0006988, IGF1, and miR-15a-5p were validated through dual-luciferase reporter (DLR) and RNA immunoprecipitation (RIP) assays.

RESULTS

Herein, a new circRNA, hsa_circ_0006988, was identified, and its levels were markedly enhanced in SOR-resistant (SOR-R) HCC tissues. Functionally, hsa_circ_0006988 strongly suppressed SOR toxicity . Our examination of the signaling pathway revealed that hsa_circ_0006988 sequestered miR-15a-5p, a negative modulator of IGF1, thus suggesting that hsa_circ_0006988 deficiency diminished SOR resistance of HCC, and this action utilized the release of excess miR-15a-5p, which suppressed IGF1 levels. Moreover, miR-15a-5p overexpression reversed the hsa_circ_0006988-mediated SOR-R and enhanced IGF1 levels in HCC cells.

CONCLUSION

Hsa_circ_0006988 partly promoted the SOR-R of HCC cells through miR-15a-5p sequestering and upregulation of IGF1 levels.

摘要

背景

肝细胞癌(HCC)是最常见的癌症,也是全球癌症相关死亡人数最多的癌症。最近的证据表明,环状 RNA(circRNA)在 HCC 的发病机制和转移中起着至关重要的作用,在 HCC 中明显受到调节。然而,circRNA 介导索拉非尼耐药(SOR)的潜在机制仍有待确定。

方法

通过酶联免疫吸附试验(ELISA)和定量实时聚合酶链反应(qRT-PCR)分别定量 hsa_circ_0006988、IGF1 和 miR-15a-5p 的含量。细胞计数试剂盒-8(CCK-8)用于评估 IC50。最后,通过双荧光素酶报告(DLR)和 RNA 免疫沉淀(RIP)实验验证 hsa_circ_0006988、IGF1 和 miR-15a-5p 之间的关联。

结果

在此,鉴定了一个新的 circRNA,hsa_circ_0006988,其在 SOR 耐药(SOR-R)HCC 组织中明显增强。功能上,hsa_circ_0006988 强烈抑制 SOR 毒性。我们对信号通路的研究表明,hsa_circ_0006988 结合了 miR-15a-5p,miR-15a-5p 是 IGF1 的负调节剂,这表明 hsa_circ_0006988 缺乏可降低 HCC 的 SOR 耐药性,而这种作用是通过释放过量的 miR-15a-5p 抑制 IGF1 水平来实现的。此外,miR-15a-5p 的过表达逆转了 hsa_circ_0006988 介导的 SOR-R 并增强了 HCC 细胞中的 IGF1 水平。

结论

hsa_circ_0006988 通过 miR-15a-5p 结合和上调 IGF1 水平,部分促进了 HCC 细胞的 SOR-R。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/b7cfcb24503f/CJGH2022-1206134.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/fc9834dded04/CJGH2022-1206134.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/aea2e21a81d8/CJGH2022-1206134.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/295235ad6b62/CJGH2022-1206134.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/b7cfcb24503f/CJGH2022-1206134.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/fc9834dded04/CJGH2022-1206134.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/aea2e21a81d8/CJGH2022-1206134.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/295235ad6b62/CJGH2022-1206134.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e597/9805390/b7cfcb24503f/CJGH2022-1206134.004.jpg

相似文献

1
Hsa_circ_0006988 Promotes Sorafenib Resistance of Hepatocellular Carcinoma by Modulating IGF1 Using miR-15a-5p.Hsa_circ_0006988 通过调节 IGF1 来利用 miR-15a-5p 促进肝癌索拉非尼耐药。
Can J Gastroenterol Hepatol. 2022 Dec 24;2022:1206134. doi: 10.1155/2022/1206134. eCollection 2022.
2
Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.阻断 hsa_circ_0074027 通过 miR-379-5p/IGF1 轴抑制非小细胞肺癌化疗耐药性。
Bioengineered. 2021 Dec;12(1):8347-8357. doi: 10.1080/21655979.2021.1987053.
3
Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.环状RNA hsa_circ_0005397通过调控miR-326/PDK2轴促进肝细胞癌进展。
J Gene Med. 2021 Jun;23(6):e3332. doi: 10.1002/jgm.3332. Epub 2021 Apr 16.
4
Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis.Hsa_circ_0008092 通过 miR-502-5p/CCND1 轴促进肝癌细胞增殖和转移。
Protein Pept Lett. 2022;29(7):595-604. doi: 10.2174/0929866529666220721090209.
5
Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.Hsa_circ_0026134 的表达通过海绵吸附 miR-127-5p 促进 TRIM25 和 IGF2BP3 介导的肝癌细胞增殖和侵袭。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20191418.
6
Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1.Hsa_circ_0119412 通过抑制 miR-526b-5p 来上调 STMN1,从而成为肝癌的肿瘤促进因子。
Cancer Biol Ther. 2023 Dec 31;24(1):2256951. doi: 10.1080/15384047.2023.2256951. Epub 2023 Sep 29.
7
lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p.长链非编码RNA-POIR通过吸附miR-182-5p,在肝细胞癌中同时促进上皮-间质转化并抑制索拉非尼敏感性。
J Cell Biochem. 2021 Jan;122(1):130-142. doi: 10.1002/jcb.29844. Epub 2020 Sep 20.
8
CircRNA Circ-CCND1 Aggravates Hepatocellular Carcinoma Tumorigenesis by Regulating the miR-497-5p/HMGA2 Axis.环状 RNA Circ-CCND1 通过调控 miR-497-5p/HMGA2 轴促进肝癌肿瘤发生。
Mol Biotechnol. 2022 Feb;64(2):178-186. doi: 10.1007/s12033-021-00391-y. Epub 2021 Sep 26.
9
Hsa-circ-0000098 promotes the progression of hepatocellular carcinoma by regulation of miR-136-5p/MMP2 axis.Hsa-circ-0000098 通过调控 miR-136-5p/MMP2 轴促进肝癌的进展。
Adv Clin Exp Med. 2023 Jun;32(6):689-700. doi: 10.17219/acem/157063.
10
CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.环状 RNA hsa_circ_0110102 通过 miR-580-5p/PPARα/CCL2 通路抑制巨噬细胞激活和肝癌进展。
Aging (Albany NY). 2021 Apr 23;13(8):11969-11987. doi: 10.18632/aging.202900.

引用本文的文献

1
Plasma exosomal miR-122-5p_R-1, miR-23b-3p_R + 1, and miR-15a-5p_R-1 are associated with multidrug-resistant tuberculosis.血浆外泌体miR-122-5p_R-1、miR-23b-3p_R + 1和miR-15a-5p_R-1与耐多药结核病相关。
BMC Infect Dis. 2025 Aug 25;25(1):1063. doi: 10.1186/s12879-025-11487-0.
2
CircRNAs: emerging players in tyrosine kinase inhibitor resistance mechanisms in solid tumors.环状RNA:实体瘤中酪氨酸激酶抑制剂耐药机制的新兴参与者。
Mol Biol Rep. 2025 Aug 6;52(1):796. doi: 10.1007/s11033-025-10908-2.
3
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.

本文引用的文献

1
Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1. Epstein-Barr 病毒编码的环状 RNA CircBART2.2 通过调节 PD-L1 促进鼻咽癌的免疫逃逸。
Cancer Res. 2021 Oct 1;81(19):5074-5088. doi: 10.1158/0008-5472.CAN-20-4321. Epub 2021 Jul 28.
2
The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer.抗血管内皮生长因子(VEGF)药物研发的传承:通过打破癌症血管生成的恶性循环来提高研发成功率
Cancers (Basel). 2021 Jul 8;13(14):3433. doi: 10.3390/cancers13143433.
3
Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.
Circ_0001944靶向miR-1292-5p/FBLN2轴,通过抑制铁死亡促进肝细胞癌对索拉非尼的耐药性。
Immunotargets Ther. 2024 Nov 26;13:643-659. doi: 10.2147/ITT.S463556. eCollection 2024.
4
circ_0006988 promotes gastric cancer cell proliferation, migration and invasion through miRNA-92a-2-5p/TFAP4 axis.circ_0006988 通过 miRNA-92a-2-5p/TFAP4 轴促进胃癌细胞的增殖、迁移和侵袭。
Epigenomics. 2024;16(19-20):1287-1299. doi: 10.1080/17501911.2024.2410697. Epub 2024 Oct 14.
5
Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study.血清 microRNA 谱及乙型肝炎相关性肝细胞癌中的通路:南非研究。
Int J Mol Sci. 2024 Jan 12;25(2):975. doi: 10.3390/ijms25020975.
6
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.非编码 RNA 与肝癌耐药性的相互作用:小细节的大影响。
J Transl Med. 2023 Jun 7;21(1):369. doi: 10.1186/s12967-023-04238-9.
7
Naringenin induces the cell apoptosis of acute myeloid leukemia cells by regulating the lncRNA XIST/miR-34a/HDAC1 signaling.柚皮素通过调控长链非编码RNA XIST/微小RNA-34a/组蛋白去乙酰化酶1信号通路诱导急性髓系白血病细胞凋亡。
Heliyon. 2023 May 3;9(5):e15826. doi: 10.1016/j.heliyon.2023.e15826. eCollection 2023 May.
肝癌肿瘤免疫微环境与免疫抑制治疗:综述。
Int J Mol Sci. 2021 May 28;22(11):5801. doi: 10.3390/ijms22115801.
4
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment.免疫检查点抑制剂在肝细胞癌治疗中不断演变的作用。
Vaccines (Basel). 2021 May 20;9(5):532. doi: 10.3390/vaccines9050532.
5
Gastric cancer derived exosomes mediate the delivery of circRNA to promote angiogenesis by targeting miR-29a/VEGF axis in endothelial cells.胃癌来源的外泌体通过靶向内皮细胞中 miR-29a/VEGF 轴将 circRNA 递送至促进血管生成。
Biochem Biophys Res Commun. 2021 Jun 30;560:37-44. doi: 10.1016/j.bbrc.2021.04.099. Epub 2021 May 6.
6
CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.环状 RNA hsa_circ_0110102 通过 miR-580-5p/PPARα/CCL2 通路抑制巨噬细胞激活和肝癌进展。
Aging (Albany NY). 2021 Apr 23;13(8):11969-11987. doi: 10.18632/aging.202900.
7
Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.环状 RNA circDLC1 通过与 HuR 相互作用抑制 MMP1 介导的肝癌进展。
Theranostics. 2021 Jan 1;11(3):1396-1411. doi: 10.7150/thno.53227. eCollection 2021.
8
CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.环状 RNA hsa_circRNA_104348 通过调控 miR-187-3p/RTKN2 轴和激活 Wnt/β-catenin 通路促进肝癌进展。
Cell Death Dis. 2020 Dec 14;11(12):1065. doi: 10.1038/s41419-020-03276-1.
9
hsa_circ_0001955 Enhances Proliferation, Migration, and Invasion of HCC Cells through miR-145-5p/NRAS Axis.hsa_circ_0001955通过miR-145-5p/NRAS轴增强肝癌细胞的增殖、迁移和侵袭能力。
Mol Ther Nucleic Acids. 2020 Sep 16;22:445-455. doi: 10.1016/j.omtn.2020.09.007. eCollection 2020 Dec 4.
10
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.miR-30a-5p/CLCF1 轴调控肝癌索拉非尼耐药及有氧糖酵解
Cell Death Dis. 2020 Oct 23;11(10):902. doi: 10.1038/s41419-020-03123-3.